VTIAF

Healthcare Medical Care Facilities

FamiCord AG

$3.10

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

54.04M

Avg Volume

EPS

-$0.43

52W High

$7.00

52W Low

$3.10

Div. Yield

0.0%

Valuation

P/B Ratio

9.49

P/S Ratio

0.62

EV/EBITDA

9.10

EV/Revenue

0.72

Margins

Gross Margin 56.9%

Operating Margin (0.5%)

Net Margin (8.6%)

EBITDA Margin 7.9%

Growth & Returns

Revenue Growth (YoY)

0.9%

Return on Equity

(91.0%)

Return on Assets

0.7%

Liquidity & Leverage

Current Ratio

0.69

Quick Ratio

0.64

Debt / Equity

6.86

Total Cash

12.45M

Total Debt

23.03M

About

FamiCord AG engages in the collection, processing, storage, and distribution of cells, tissues, blood, and blood components for medical applications in Germany, Poland, Switzerland, Portugal, and internationally. The company operates through Subgroup Vita 34 And Subgroup PBKM segments. It produces and develops advanced therapies, genetic tests, and analyses for third parties. The company also engages in the development and manufacture of cell and tissue-based products and pharmaceuticals, including the production of viral vectors or comparable products. In addition, it engages in research and development, storage, and cryopreservation of sperm and oocytes for use in reproductive medicine; and the manufacturing and distribution of medical devices. The company was formerly known as VITA 34 AG and changed its name to FamiCord AG in February 2025. FamiCord AG was founded in 1997 and is headquartered in Leipzig, Germany.